Caris Life Sciences
Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology. The company offers a comprehensive tumor profiling service known as Caris Molecular Intelligence, which analyzes DNA, RNA, and proteins to help oncologists identify potential treatment options. Caris also operates a platform called Caris CODEai that integrates molecular data with clinical outcomes to support research and drug development. Its services cater to biopharma partners, healthcare providers, and academic institutions aiming to improve cancer diagnostics and therapy selection. The company incorporates machine learning models to discover new biomarkers and therapeutic targets based on large-scale multi-omic data.
Domain
carislifesciences.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
1001-5000
Last Funding
$168.0M
Founded
2007
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Caris Life Sciences use?+
Caris Life Sciences uses 14 technologies including Google Tag Manager, OneTrust, reCAPTCHA.
What industry is Caris Life Sciences in?+
Caris Life Sciences operates in the Artificial Intelligence (AI) industry.
Where is Caris Life Sciences based?+
Caris Life Sciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026